Aurora Labs Limited
Aurora Labs Limited (A3D.AX) Financial Performance & Income Statement Overview
Analyze Aurora Labs Limited (A3D.AX) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Aurora Labs Limited (A3D.AX) Income Statement & Financial Overview
Explore comprehensive income reports for Aurora Labs Limited A3D.AX, broken down by year and quarter.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $236736.00 | $25410.00 | $148750.00 | $71314.00 |
| Cost of Revenue | $1.97M | $1.11M | $1.28M | $1.39M |
| Gross Profit | $85526.00 | -$1.09M | -$1.13M | -$1.32M |
| Gross Profit Ratio | $0.36 | -$42.86 | -$7.59 | -$18.53 |
| R&D Expenses | $368896.00 | $253664.00 | $196262.00 | $121321.00 |
| SG&A Expenses | $1.97M | $341781.00 | $342115.00 | $404558.00 |
| Operating Expenses | $807307.00 | $595355.00 | $538377.00 | $525879.00 |
| Total Costs & Expenses | $2.49M | $1.71M | $1.82M | $1.92M |
| Interest Income | $171.00 | $19.00 | $25.00 | $61.00 |
| Interest Expense | $39097.00 | $12040.00 | $35488.00 | $10119.00 |
| Depreciation & Amortization | $93658.00 | $90269.00 | $75640.00 | $81210.00 |
| EBITDA | -$2.52M | -$1.64M | -$1.59M | -$1.77M |
| EBITDA Ratio | -$10.65 | -$64.54 | -$10.71 | -$24.77 |
| Operating Income | -$2.26M | -$1.68M | -$1.67M | -$1.85M |
| Operating Income Ratio | -$9.53 | -$66.27 | -$11.21 | -$25.90 |
| Other Income/Expenses (Net) | -$330000.00 | -$57780.00 | -$36232.00 | -$10419.00 |
| Income Before Tax | -$2.59M | -$1.74M | -$1.70M | -$1.86M |
| Income Before Tax Ratio | -$10.92 | -$68.56 | -$11.46 | -$26.05 |
| Income Tax Expense | $0.00 | -$640000.00 | $0.00 | -$589468.00 |
| Net Income | -$2.59M | -$1.10M | -$1.70M | -$1.27M |
| Net Income Ratio | -$10.92 | -$43.37 | -$11.46 | -$17.79 |
| EPS | -$0.007 | -$0.003 | -$0.007 | -$0.005 |
| Diluted EPS | -$0.007 | -$0.003 | -$0.007 | -$0.005 |
| Weighted Avg Shares Outstanding | $374.80M | $346.56M | $254.31M | $242.19M |
| Weighted Avg Shares Outstanding (Diluted) | $374.80M | $346.56M | $254.31M | $242.19M |
Over the last four quarters, Aurora Labs Limited's revenue moved from $71314.00 in Q4 2023 to $236736.00 in Q2 2025. Operating income in Q2 2025 was -$2.26M, with a strong operating margin of -953%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Aurora Labs Limited remained robust at -$2.52M, reflecting operational efficiency. Net income dropped to -$2.59M, with an EPS of -$0.007. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan